Genetic Insights from Feline Cancer Research Could Inform Human Breast Cancer Treatments

A recent large-scale study has revealed significant genetic similarities between cancers in domestic cats and humans, particularly in breast cancer. Conducted by researchers from the Wellcome Sanger Institute, the Ontario Veterinary College, and the University of Bern, the study analyzed tumors from nearly 500 cats across five countries. The findings, published in *Science*, indicate that certain genetic mutations found in feline cancers closely mirror those in human cancers, suggesting potential pathways for improved treatment options for both species.

SciTechDaily

The research identified key mutations in feline mammary tumors, such as FBXW7 and PIK3CA, which are also prevalent in human breast cancer. FBXW7 mutations were found in over 50% of feline tumors, and similar mutations in PIK3CA appeared in 47% of feline mammary tumors. These genetic alterations could lead to targeted therapies, as existing treatments for human breast cancer, such as PI3K inhibitors, may also be effective in cats. The study highlights the potential for a "One Medicine" approach, where insights from veterinary oncology could inform human cancer treatments and vice versa.

SciTechDaily

Bailey Francis, co-first author at the Wellcome Sanger Institute, emphasized the importance of cross-species cancer research, stating, “By comparing cancer genomics across different species, we gain a greater understanding of what causes cancer.” Professor Geoffrey Wood from the Ontario Veterinary College noted the lack of prior knowledge regarding feline cancer genetics, stating, “Despite domestic cats being common pets, there was very little known about the genetics of cancer in these animals until now.” This research opens new avenues for understanding cancer development influenced by shared environmental factors.

SciTechDaily

The study marks a significant advancement in feline oncology, providing a comprehensive genetic profile of domestic cat tumors. Professor Sven Rottenberg from the University of Bern remarked on the unprecedented scale of the research, stating, “Having access to such a large set of donated tissues allowed us to assess drug responses across tumor types in a way that hasn’t been possible at this scale before.” This resource is expected to facilitate the identification of novel therapeutic options for both cats and humans.

SciTechDaily

The findings of this study pave the way for further research into shared genetic changes that could lead to new cancer therapies. The collaborative nature of this research, supported by organizations such as the EveryCat Health Foundation and the Wellcome Trust, underscores the potential for significant advancements in both veterinary and human medicine.

SciTechDaily

• “Bailey Francis, co-first author at the Wellcome Sanger Institute, said, “By comparing cancer genomics across different species, we gain a greater understanding of what causes cancer.” — Bailey Francis, Co-first Author, Wellcome Sanger Institute

SciTechDaily

• “ Professor Geoffrey Wood, co-senior author at the Ontario Veterinary College, Canada, said, “Despite domestic cats being common pets, there was very little known about the genetics of cancer in these animals until now.” — Professor Geoffrey Wood, Co-senior Author, Ontario Veterinary College

SciTechDaily

This research represents a pivotal step towards enhancing cancer treatment strategies through the integration of knowledge from both human and veterinary medicine.

SciTechDaily